Blys fusion proteins for targeting blys receptor and methods...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 14/415 (2006.01) C07K 14/525 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2595904

The present invention regards targeted BLyS polypeptides capable of binding to BLyS receptors and that deliver a cytotoxic agent, such as a cytotoxic peptide, for example. In particular aspects, the cytotoxic agent comprises at least part of rGelonin. These compositions are useful for treating, preventing, and/or monitoring therapy for a B-cell proliferative disorder.

La présente invention concerne des polypeptides BLyS ciblés qui peuvent se lier à des récepteurs de BLyS et qui délivrent un agent cytotoxique, par exemple, un peptide cytotoxique. Selon des aspects particuliers, l'agent cytotoxique comprend au moins une partie de of rGelonine. Ces compositions permettent de traiter, de prévenir et/ou de surveiller le traitement d'un trouble prolifératif des lymphocytes B.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Blys fusion proteins for targeting blys receptor and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blys fusion proteins for targeting blys receptor and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blys fusion proteins for targeting blys receptor and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732092

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.